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The border-land of epilepsy-Revisited
In his 1907 book, The Border-land of Epilepsy, William R. Gowers 1 wrote in the Preface that he "kept a special list of all cases which seemed to be in the border-land of epilepsy-near it, but not of it.
[w]hen these cases were collected and classified, their comparison and study revealed a large number of unfamiliar facts and many instructive lessons, throwing light on the nature of the affections, and on their relation to epilepsy, and on questions of practical diagnosis." Depression, or at least depressed moods in people with epilepsy, was not on Gowers's list but should now be added to the borderlands as it is near it, but not of it too. Epilepsy specialists often recognize the connection between depression and epilepsy, as depression is more common in their selected population with the most intractable epilepsy; yet the magnitude of the problem of depression in epilepsy is probably not as well-recognized by general neurologists and primary care physicians.
In this issue of Neurology ® , Fiest et al. 2 report the results of a systematic review of more than 7,000 published works on the association of epilepsy and depression. The strength of their article is the meta-analysis of the prevalence as well as the association between epilepsy and active depression (defined as current depression or within the past year). The data on the association of epilepsy and lifetime depression are less robust because of a smaller number of qualifying articles with more methodologic issues. The overall prevalence of active depression was 23.1% (95% confidence interval [CI] 19.8%-27.0%) in 9 studies involving 29,891 people with epilepsy. The odds ratios (OR)-that is, the odds of depression in people with epilepsy relative to the odds of depression in people without epilepsyare more difficult to determine, because of variations in the handling of confounding variables in the individual studies as well as the general difficulty with the OR methodology itself. 3 However, the OR findings also support the association between epilepsy and depression. The association of epilepsy and active depression had an estimated pooled OR of 2.77 (95% CI 2.09-3.67) in 5 studies involving 1,217,024 people. Systematic reviews of this type are difficult to perform because of heterogenous presentation of the conditions under study. The authors had to contend with the variety of presentations of epilepsy and mood disorders as clinical syndromes, as well as methodologic differences among the analyzed publications in regards to clinical characteristics and ascertainment methods for epilepsy and depression. For example, depression was self-defined in some studies, detected using diagnostic codes in others, and determined by a variety of clinical rating scales in others. One of the publications used an administrative code set not validated for epilepsy or depression to identify subjects. Exclusion of this study would have increased the lifetime prevalence of depression and epilepsy to nearly 20%, a figure similar to the active depression prevalence they found. Because of this heterogeneity, it might be better to say that patients with epilepsy have an increased prevalence of a mood disorder and not to assume that everyone had major depressive disorder. By way of comparison, recent epidemiologic survey data show that the 12-month prevalence estimate of depression in the United States is 8.6%, post-traumatic stress disorder is 3.7%, and bipolar disorder is 1.8%. 4 This systematic review clearly answers the question that depression frequently accompanies epilepsy but leaves for future research what should be done with this information. How should a neurologist approach the care of patients with epilepsy when 1 out of 4 has active depression or some other depressive mood disorder? Should the risk of depression influence the choice of anticonvulsant medication in light of the 2008 Food and Drug Administration Alert? That Alert presented an analysis of clinical trial data of suicidality reports on 11 anticonvulsant drugs, and showed that patients taking these anticonvulsant drugs had about twice the rate of suicidal thoughts as those taking placebo, a risk estimated at 2.1 per 1,000 patients higher in the treatment group. 5 How do you sort out depression in epilepsy from other comorbid conditions such as posttraumatic stress disorder and bipolar disorder? For example, more than 1 in 3 women (35.6%) and more than 1 in 4 men (28.5%) in the United States have experienced rape, physical violence, or stalking by an intimate partner in their lifetime, with 18.3% of women and 1.4% of men reporting a history of being raped, according to the 2010 National Intimate Partner and Sexual Violence Survey. 6 From the Department of Neurology, Henry Ford Hospital; and Department of Neurology, Wayne State University, Detroit, MI.
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Once a diagnosis of depression or other mood disorder is made, should a neurologist institute treatment for patients with epilepsy and depression? Certainly, it is within the scope of training and expertise of American neurologists to do so, at least for less complex mood disorders. This may not be the case in other countries but in the United States, neurology residents must be trained in "the principles of psychopathology, psychiatric diagnosis, and therapy and the indications for and complications of drugs used in psychiatry." 7 The American Board of Psychiatry and Neurology (ABPN) states "the Board requires proficiency in neurology on the part of those it certifies in psychiatry and vice versa." 8 About 20% of the questions on the initial ABPN Certification Examination in Neurology are comprised of questions related to psychiatry. 9 In addition, depression screening and treatment are 2 of the current Physician Quality Reporting System measures available to any physician.
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Epilepsy care thus joins behavioral neurology where the overlap of psychiatry and neurology forms a continuum. A familiarity and comfort with the use of medications and counseling techniques for mood disorders should be a part of neurology practice.
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